Related Experiment Videos
DNA diagnosis of familial hypercholesterolemia
1Franz Volhard Clinic, Max Delbrück Center for Molecular Medicine, Virchow Klinikum, Humboldt University of Berlin, Germany. schuster@mdc-berlin.de
Insights
New genetic testing identifies individuals at high risk for arteriosclerotic cardiovascular diseases. This oligonucleotide ligation assay (OLA) offers a reliable, automated method for genetic screening in large populations.
Area of Science:
- Cardiovascular Genetics
- Molecular Diagnostics
- Genetic Epidemiology
Background:
- Arteriosclerotic cardiovascular diseases cause over half of deaths in Western societies.
- Inherited defects in low-density-lipoprotein (LDL) receptors contribute significantly to these conditions.
- Current lipoprotein tests lack genetic inference capabilities.
Purpose of the Study:
- To develop a genetic screening method for identifying individuals at high risk for arteriosclerotic cardiovascular diseases.
- To enable genetic epidemiological data collection and cost-effective case finding.
Main Methods:
- Development of an oligonucleotide ligation assay (OLA).
- Utilizing automated genotyping equipment for mutation screening.
- Testing for common mutations associated with lipid-related defects.
Main Results:
- The OLA is robust, reliable, objective, and automated.
- The assay can screen large populations for genetic risk factors.
- Distinguishes between relative and absolute risk.
Conclusions:
- The OLA provides a valuable tool for genetic screening of cardiovascular disease risk.
- Facilitates genetic epidemiological studies and family-based case finding.
- Offers a more informative approach than traditional lipoprotein testing.
Abstract:
More than half of all deaths in western societies are related to arteriosclerotic cardiovascular diseases. Inherited disturbances in the low-density-lipoprotein (LDL) receptor and similar lipid-related defects account for more than half. Testing procedures thus far rely on lipoprotein determinations. These tests are not able to provide any genetic inference. We have developed an oligonucleotide ligation assay (OLA) which enables us to screen for high risk individuals by testing for common mutations in using automated genotyping equipment. Since the test is robust, reliable, objective, fool proof, and automated, it will be useful in screening large population to gather genetic epidemiological data, distinguish relative from absolute risk, as well as for cost effective case finding in family studies.